Rome, Italy — February 10, 2026 — IRBM, a leader in early drug discovery research,…
Prestigious bilingual publication highlights 30 standout companies shaping the future of Italian enterprise—from design and…
De-Risking Target Validation with Data-Driven Genomic Insights ROME, April 3, 2025 /originally distributed by PRNewswire/– IRBM, an…
Dublin, Ireland, and Rome, Italy, 20 May 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing…
